职业安全威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 职业安全威廉亚洲博彩公司

针刺伤防护专家共识

2018-08-01 中华护理学会护理管理专业委员会 中华护理学会护理管理专业委员会

针刺伤防护

针刺伤是当今医务工作者面临的严重职业危险因素之一。可引起血源性疾病的传播，威胁着医务人员生命健康和职业安全，给暴露者带来极大的精神心理压力，也给医疗卫生机构和暴露者带来沉重的经济负担。护理人员针刺伤及由针刺伤所致的血源性传播疾病的发生率均高于其他医务工作者，是针刺伤高危人群。我国目前尚无针刺伤防护的相关专家共识。

中文标题：

针刺伤防护专家共识

发布机构：

中华护理学会护理管理专业委员会

发布日期：

2018-08-01

简要介绍：

针刺伤是当今医务工作者面临的严重职业危险因素之一。可引起血源性疾病的传播，威胁着医务人员生命健康和职业安全，给暴露者带来极大的精神心理压力，也给医疗卫生机构和暴露者带来沉重的经济负担。护理人员针刺伤及由针刺伤所致的血源性传播疾病的发生率均高于其他医务工作者，是针刺伤高危人群。我国目前尚无针刺伤防护的相关专家共识。 

拓展威廉亚洲博彩公司 ：与防护相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=针刺伤防护专家共识)] GetToolGuiderByIdResponse(projectId=1, id=f1c581c00163a078, title=针刺伤防护专家共识, enTitle=, guiderFrom=中华护理学会护理管理专业委员会, authorId=null, author=, summary=针刺伤是当今医务工作者面临的严重职业危险因素之一。可引起血源性疾病的传播，威胁着医务人员生命健康和职业安全，给暴露者带来极大的精神心理压力，也给医疗卫生机构和暴露者带来沉重的经济负担。护理人员针刺伤及由针刺伤所致的血源性传播疾病的发生率均高于其他医务工作者，是针刺伤高危人群。我国目前尚无针刺伤防护的相关专家共识。 , cover=, journalId=null, articlesId=null, associationId=1696, associationName=中华护理学会护理管理专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>针刺伤是当今医务工作者面临的严重职业危险因素之一。可引起血源性疾病的传播，威胁着医务人员生命健康和职业安全，给暴露者带来极大的精神心理压力，也给医疗卫生机构和暴露者带来沉重的经济负担。护理人员针刺伤及由针刺伤所致的血源性传播疾病的发生率均高于其他医务工作者，是针刺伤高危人群。我国目前尚无针刺伤防护的相关专家共识。 </div> <div><br> </div>拓展威廉亚洲博彩公司 ：<strong>与<font color="red">防护</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a title="放射性125I粒子病房辐射防护管理规范专家共识" target="_blank" href="//www.nyrain.com/guideline/show_article.do?id=4e0b11c001a84396">放射性125I粒子病房辐射防护管理规范专家共识</a></li> <li><a title="2016 守护针尖上的安全—中国输液安全与防护专家共识" target="_blank" href="//www.nyrain.com/guideline/show_article.do?id=305ad1c0012a49bf">2016 守护针尖上的安全—中国输液安全与防护专家共识</a></li> <li><a title="埃博拉出血热个人防护威廉亚洲博彩公司 （第二版）" target="_blank" href="//www.nyrain.com/guideline/show_article.do?id=12b431c0011068b8">埃博拉出血热个人防护威廉亚洲博彩公司 （第二版）</a></li> <li><a title="中国疾病预防控制中心关于埃博拉出血热个人防护技术方案威廉亚洲博彩公司 （第一版）（试行）" target="_blank" href="//www.nyrain.com/guideline/show_article.do?id=277f21c001099952">中国疾病预防控制中心关于埃博拉出血热个人防护技术方案威廉亚洲博彩公司 （第一版）（试行）</a></li> <li><a title="医用X射线诊断放射防护要求" target="_blank" href="//www.nyrain.com/guideline/show_article.do?id=dfe7f1c001032965">医用X射线诊断放射防护要求</a></li> 更多信息请点击：<a target="_blank" href="//www.nyrain.com/guideline/list.do?q=%E9%98%B2%E6%8A%A4">有关防护更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=79968, tagName=针刺伤防护)], categoryList=[CategoryDto(categoryId=75, categoryName=职业安全, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=21501, appHits=395, showAppHits=0, pcHits=14232, showPcHits=8634, likes=132, shares=31, comments=4, approvalStatus=1, publishedTime=Fri Aug 31 22:54:57 CST 2018, publishedTimeString=2018-08-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 31 22:54:57 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 22:01:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=针刺伤防护专家共识)])
针刺伤防护专家共识
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=366760, encodeId=f0f0366e60b0, content=学习了，受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/25/2db8942dbe3fddb827ba7654c1746313.jpg, createdBy=b7935108330, createdName=梦婷婷, createdTime=Sat May 25 14:40:55 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342198, encodeId=77663421983e, content=专家共识，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sun Sep 02 07:34:24 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342093, encodeId=ff8f342093d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:50 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342027, encodeId=8dd834202e51, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 31 23:25:38 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2019-05-25 梦婷婷

    学习了，受益匪浅。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=366760, encodeId=f0f0366e60b0, content=学习了，受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/25/2db8942dbe3fddb827ba7654c1746313.jpg, createdBy=b7935108330, createdName=梦婷婷, createdTime=Sat May 25 14:40:55 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342198, encodeId=77663421983e, content=专家共识，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sun Sep 02 07:34:24 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342093, encodeId=ff8f342093d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:50 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342027, encodeId=8dd834202e51, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 31 23:25:38 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2018-09-02 liumin1987

    专家共识，学习了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=366760, encodeId=f0f0366e60b0, content=学习了，受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/25/2db8942dbe3fddb827ba7654c1746313.jpg, createdBy=b7935108330, createdName=梦婷婷, createdTime=Sat May 25 14:40:55 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342198, encodeId=77663421983e, content=专家共识，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sun Sep 02 07:34:24 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342093, encodeId=ff8f342093d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:50 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342027, encodeId=8dd834202e51, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 31 23:25:38 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2018-09-01 医者仁心5538

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=366760, encodeId=f0f0366e60b0, content=学习了，受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/25/2db8942dbe3fddb827ba7654c1746313.jpg, createdBy=b7935108330, createdName=梦婷婷, createdTime=Sat May 25 14:40:55 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342198, encodeId=77663421983e, content=专家共识，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sun Sep 02 07:34:24 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342093, encodeId=ff8f342093d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:50 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342027, encodeId=8dd834202e51, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 31 23:25:38 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2018-08-31 1209e435m98(暂无昵称)

    学习了，谢谢分享

    0